Full results & analysis
Available in the Gosset platform where reported.
01
Overview
Phase 4, randomised, double-blind trial of colistin and neomycin in colonization by Enterobacteriaceae (2 arms). Primary endpoint: Rate of eradication of carriage with ESBL-producing Enterobacteriaceae at 28 days. Started Jun 2009; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Topical decolonization
Colistin sulphate + Neomycin (+/- Nitrofurantoin or Norfloxacin)
Placebo
Placebo
03
Who it enrols
Patients with microbiologically documented rectal carriage of ESBL-producing Enterobacteriaceae without active infection.
04
Endpoints
Primary
Rate of eradication of carriage with ESBL-producing Enterobacteriaceae
Beyond the preview
Go deeper on NCT00826670.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00826670.